• Mon, June 15, 2015
  • Tue, June 16, 2015
  • Thu, June 18, 2015
  • Wed, June 17, 2015

Matthew Luchini Maintained (BLUE) at Buy with Increased Target to $239 on, Jun 15th, 2015

Matthew Luchini of BMO Capital, Maintained "bluebird bio, Inc." (BLUE) at Buy with Increased Target from $200 to $239 on, Jun 15th, 2015.

Matthew has made no other calls on BLUE in the last 4 months.



There is 1 other peer that has a rating on BLUE. Out of the 1 peers that are also analyzing BLUE, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Jason McCarthy of "Maxim Group" Initiated at Strong Buy and Held Target at $190 on, Wednesday, April 22nd, 2015